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Abstract
Backround: Plumeria acuminata belonging to the family Apocynaceae is commonly known as
'perungalli' in Tamil and is widely distributed throughout the Southern parts of India. In traditional
medicinal system different parts of the plant have been mentioned to be useful in a variety of
diseases. The plant material is widely used as a purgative, remedy for diarrhoea and cure for itch.
The milky juice is employed for the treatment of inflammation and rheumatism. The bark has been
reported to be useful in hard tumors, diarrhoea and gonorrhoea. The objective of the present
study was to evaluate the antiinflammatory activity of methanol extract of leaves of Plumeria
acuminata on carrageenan, dextran, histamine and serotonin-induced inflammation in rat hind paw
oedema models.
Methods: Acute and chronic inflammation models were used to evaluate the anti-inflammatory
activity of the extract. Wistar albino rats of either sex weighing 180–200 g were used. In acute
model carrageenan, dextran, histamine and serotonin models were used to induce inflammation in
rat hind paw and cotton pellet-induced granuloma method was used for chronic inflammation
model. In each model four groups of six animals were used. In all the models Group I served as
control (0.9% normal saline, 5 mlkg-1 b.w) and group IV as standard (Indomethacin 10 mgkg-1 b.w).
Group II and III received extract at the doses of 250 and 500 mgkg-1 b.w respectively.
Results: The methanol extract of Plumeria acuminata exhibited significant anti-inflammatory activity
on the tested experimental animal models. The extract (500 mgkg-1 b.w) exhibited maximum
antiinflammatory effect i.e., 30.51, 47.06, 34.48 and 32.50% (P < 0.001) at the end of 3 h with
carrageenan, dextran, histamine and serotonin respectively. Administration of MEPA (500 mgkg-1
b.w) and indomethacin (10 mgkg-1 b.w) significantly reduced the formation of granuloma tissue
induced by cotton pellet method at a rate of 45.06 and 51.57% respectively. The effect produced
by the extract was comparable to that of indomethacin a prototype of a nonsteroidal
antiinflammatory agent.
Conclusion: The results obtained in this study indicated that the methanol extract of Plumeria
acuminata possess potent antiinflammatory activity in both acute and chronic models.
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Background
In Indian system of medicine, a large number of drugs of
either herbal or mineral origin have been advocated for
various types of diseases and other different unwanted
conditions in humans [1]. Ayurveda is one of the tradi-
tional systems of medicine practiced in India and Sri
Lanka and can be traced back to 6000 BC [2]. Ayurvedic
medicines are largely based upon herbal and herbomin-
eral preparations and have specific diagnostic and thera-
peutic principles [3].
Inflammation is a disorder involving localized increases
in the number of leukocytes and a variety of complex
mediator molecules [4]. Prostaglandins are ubiquitous
substances that indicate and modulate cell and tissue
responses involved in inflammation. Their biosynthesis
has also been implicated in the pathophysiology of cardi-
ovascular diseases, cancer, colonic adenomas and Alzhe-
imer's disease [5,6].
Medicinal plants are believed to be an important source of
new chemical substances with potential therapeutic
effects [7,8]. The research into plants with alleged folk-
loric use as pain relievers, antiinflammatory agents,
should therefore be viewed as a fruitful and logical
research strategy in the search for new analgesic and anti-
inflammatory drugs [9].
Plumeria acuminata belonging to the family Apocynaceae
is commonly known as 'perungalli' in Tamil and widely
distributed throughout the Southern parts of India. In tra-
ditional medicinal system different parts of the plant have
been mentioned to be useful in a variety of diseases. The
plant material is widely used as a purgative, remedy for
diarrhoea and cure for itch. The milky juice is employed
for the treatment of inflammation and rheumatism. The
bark has been applied as a plaster over inflammation and
hard tumors. The leaves are reported to have antiinflam-
matory, rubefacient in rheumatism and have strong pur-
gative effect. Its branches are used like those of 'chitraka' to
produce abortion [10]. However there is no scientific
report or verification of the use of this plant in the treat-
ment of these conditions. Accordingly a pharmacological
investigation on the methanol extract of leaves of Plumeria
acuminata (MEPA) has been initiated in our laboratory
and here we report the preliminary result of studies on
acute toxicity and antiinflammatory effects on experimen-
tal models.
Methods
Plant material
The leaves of the plant Plumeria acuminata (Family: Apocy-
naceae) was collected from Erode district of Tamilnadu,
India. The plant material was taxonomically identified by
Botanical Survey of India, Kolkata. A voucher specimen
(No. GMG 02/05) has been preserved in our laboratory
for future reference. The leaves were dried under shade
and then powdered with a mechanical grinder and stored
in airtight container. The dried powder material of the
leaves was defatted with petroleum ether and the marc
thus obtained was then extracted with methanol in a
soxhlet apparatus. The solvent was completely removed
under reduced pressure and a semisolid mass was
obtained (MEPA, yield 12.4%). The dried MEPA was sus-
pended in normal saline and used for the present study.
Drugs
Carrageenan (S.D. Fine Chemicals Limited, Bombay), 5-
hydroxytryptamine hydrochloride (Serotonin), histamine
and dextran (Sigma, USA) were used in the study and
indomethacin (Recon, Bangalore) was used as the stand-
ard drug.
Animals
Studies were carried out using Wistar albino rats of either
sex weighing 180–200 g and Swiss albino mice of either
sex weighing 18–22 g. They were obtained from the ani-
mal house, Indian Institute of Chemical Biology (IICB),
Kolkata, India. The animals were grouped in polyacrylic
cages (38 cm × 23 cm × 10 cm) with not more than six ani-
mals per cage and maintained under standard laboratory
conditions (temperature 25 ± 2°C) with dark and light
circle (14/10 h). They were allowed free access to standard
dry pellet diet (Hindustan Lever, Kolkata, India) and
water ad libitum. The rats were acclimatized to laboratory
condition for 10 days before commencement of experi-
ment. All procedures described were reviewed and
approved by the university animal ethical committee.
Phytochemical screening
The extract was screened for the presence of various con-
stituents employing standard screening test [11]. Conven-
tional protocol for detecting the presence of steroids,
alkaloids, tannins, flavonoids, glycosides, etc., was used.
Acute toxicity test
The animals were divided into six groups containing eight
animals in each group. MEPA was suspended in normal
saline and administered orally as a single dose to groups
of mice at different concentrations (500, 750, 1000, 1250,
1500 and 2000 mgkg-1 b.w). These animals were observed
for a 72 h period. The number of deaths was expressed as
a percentile and the LD50 was determined by probit a test
using the death percentage versus the log dose [12].
Antiinflammatory activity
Carrageenan-induced rat paw oedema
The rats were divided into four groups (n = 6). The differ-
ent groups were treated orally with MEPA (250 and 500
mgkg-1 b.w), indomethacin (10 mgkg-1 b.w), and vehicleBMC Complementary and Alternative Medicine 2006, 6:36 http://www.biomedcentral.com/1472-6882/6/36
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control (0.9% NaCl, 5 mlkg-1 b.w). The administration of
extract and drugs was 30 min prior to injection of 0.1 ml
of 1% freshly prepared suspension of carrageenan in nor-
mal saline in the right hind paw subplantar of each rat.
The paw volume was measured initially and then at 1, 2,
3 and 4 h after the carrageenan injection by using plethys-
mometer [13]. The antiinflammatory effect of MEPA was
calculated by the following equation:- Antiinflammatory
activity (%) = (1-D/C) × 100, where D represents the per-
centage difference in paw volume after the administration
of drugs to the rats and C represents the percentage differ-
ence of volume in the control groups [14].
Dextran-induced rat paw oedema
The animals were treated in a manner similar to that of
carrageenan-induced paw oedema models; dextran (0.1
ml, 1% w/v in normal saline) was used in the place of car-
rageenan [13].
Histamine-induced rat paw oedema
In this model hind paw oedema in the right foot of a rat
was induced by subplantar injection of 0.1 ml of 1%
freshly prepared histamine in normal saline and the paw
oedema was measured as mentioned earlier [14].
Serotonin-induced rat paw oedema
In another model oedema of the right hind paws of the rat
was induced by subplantar injection of 0.1 ml of 1%
freshly prepared serotonin in normal saline. Group divi-
sion and treatment of the animals were the same as the
Carrageenan-induced rat paw oedema model and the paw
volume was measured as mentioned in Winter et al., 1962
[15].
Cotton pellet-induced granuloma
The cotton pellets-induced granuloma in rats was studied
according to the method D'Arcy et al., 1960 [16]. The ani-
mals were divided into four groups of six animals in each
group. The rats were anaesthetized and sterile cotton pel-
lets weighing 10 ± 1 mg were implanted subcutaneously
into both sides of the groin region of each rat. Group I
served as control and received the vehicle (0.9% NaCl, 5
mlkg-1 b.w. The extract MEPA at the concentration of 250
and 500 mgkg-1 b.w was administered orally to groups II
and III animals for seven consecutive days from the day of
cotton pellet implantation. Group IV animals received
indomethacin at a dose of 10 mgkg-1 b.w for the same
period. On 8th day the animals were anaesthetized and the
pellets together with the granuloma tissues were carefully
removed and made free from extraneous tissues. The wet
pellets were weighed and then dried in an oven at 60°C
for 24 h to constant weight, after that the dried pellets
were weighed again. Increment in the dry weight of the
pellets was taken as a measure of granuloma formation.
The antiproliferative effect of MEPA was compared with
control.
Statistical analysis
The values were expressed as mean ± S.E.M. The statistical
significance was determined by using the student t-test
[17]. Values of P < 0.001 were considered as statistically
significant.
Results
Phytochemical screening
Preliminary phytochemical screening of the methanol
extract revealed the presence of steroids, flavonoids, tan-
nins, alkaloids and glycosides. Further separation of the
specific phytochemical is in progress.
Acute toxicity test
In the acute toxicity assay no deaths were observed during
the 72 h period at the doses tested. At these doses, the ani-
mals showed no stereotypical symptoms associated with
toxicity, such as convulsion, ataxy, diarrhoea or increased
diuresis. The median lethal dose (LD50) was determined
to be higher than highest dose tested i.e., 2.0 gkg-1 b.w.
Carrageenan-induced rat paw oedema
The antiinflammatory activity of MEPA was measured at
the dose of 250 and 500 mgkg-1 b.w against acute paw
oedema induced by carrageenan is summarized in Figure
1. The MEPA produced significant (P < 0.001) antiinflam-
matory activity and the results were comparable to that of
indomethacin as a standard antiinflammatory drug.
MEPA at the doses 250 and 500 mg/kg moderately inhib-
ited (22.03 and 30.51%) the carrageenan-induced rat paw
oedema and it has less activity compared to other models.
Dextran-induced paw oedema
The differences in the paw volume after the administra-
tion of MEPA and standard drug indomethacin were pre-
sented in Figure 1b. The extract produced significant
antiinflammatory activity and the results were compara-
ble to that of the standard drug indomethacin. MEPA
exhibited 43.14 and 47.06% of inhibition at the dose of
250 and 500 mgkg-1 b.w respectively in dextran-induced
paw oedema in rats.
Histamine and serotonin-induced paw oedema
The antiinflammatory effect of MEPA against acute pedal
oedema induced by phlogistic agents histamine and sero-
tonin has been shown in Figures 1c and 1d. MEPA showed
significant antiinflammatory activity and the results were
comparable to that of indomethacin a prototype of a non-
steroidal antiinflammatory drug. The extract (500 mgkg-1)
showed a maximum 34.48% inhibition in histamine and
32.50% inhibition in serotonin-induced rat paw oedema.BMC Complementary and Alternative Medicine 2006, 6:36 http://www.biomedcentral.com/1472-6882/6/36
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Cotton pellets-induced granuloma
The effects of MEPA and indomethacin on the prolifera-
tive phase of inflammation are shown in table 1. A signif-
icant reduction in the weight of cotton pellets was
observed with MEPA (250 and 500 mgkg-1 b.w) compared
to the vehicle treated rats. However the degree of reduc-
tion was less than the effect caused by indomethacin.
Discussion and conclusion
The present study establishes the antiinflammatory activ-
ity of the methanol extract of the leaves of Plumeria acumi-
nata in the models used. Using acute toxicity assay, the
median lethal dose, LD50 was determined to be higher
than 2.0 gkg-1 b.w. In this assay, neither deaths nor symp-
toms associated with toxicity such as convulsion, ataxy,
diarrhoea or increased diuresis occurred during the 72 h
observation period. These results indicate the effective-
ness and relative safety of MEPA for the treatment of con-
ditions associated with inflammation.
Carrageenan-induced oedema has been commonly used
as an experimental animal model for acute inflammation
and is believed to be biphasic. The early phase (1 – 2 h) of
the carrageenan model is mainly mediated by histamine,
serotonin and increased synthesis of prostaglandins in the
damaged tissue surroundings. The late phase is sustained
by prostaglandin release and mediated by bradykinin, leu-
kotrienes, polymorphonuclear cells and prostaglandins
Effect of MEPA on carrageenan-induced rat paw oedema Figure 1
(A) Effect of MEPA on carrageenan-induced rat paw oedema. (B) Effect of MEPA on dextran-induced rat paw oedema. (C) 
Effect of MEPA on histamine-induced rat paw oedema. (D) Effect of MEPA on serotonin-induced rat paw oedema. In all the 
graphs. Values are mean ± S.E.M. (n = 6). Variation compared to the control animals. * (P < 0.001) ** (P < 0.01).
Figure 1. Effect of MEPA on carrageenan-induced rat paw oedema
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Figure 2. Effect of MEPA on dextran-induced rat paw oedema
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Figure 3. Effect of MEPA on histamine-induced rat paw oedema
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Figure 4. Effect of MEPA on serotonin-induced rat paw oedema
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produced by tissue macrophages [18]. The inhibitory
activity shown by the extract of Plumeria acuminata leaves
(250 and 500 mgkg-1 b.w) over a period of 4 h in carra-
geenan, dextran. Serotonin and histamine-induced paw
inflammation was quite similar to that exhibited by the
group treated with indomethacin. These results indicate
that the extract acts in later phases probably involving ara-
chidonic acid metabolites, which produce an oedema
dependent on neutrophils mobilization [19].
The cotton pellet method is widely used to evaluate the
transudative and proliferative components of the chronic
inflammation. The wet weight of the cotton pellets corre-
lates with the transuda; the dry weight of the pellets corre-
lates with the amount of the granulomatous tissue
[20,21]. Administration of MEPA (250 and 500 mgkg-1
b.w) and indomethacin (10 mgkg-1 b.w) appear to be
effective in inhibiting the wet weight of cotton pellet. On
the other hand, the MEPA effect on dry weight of the cot-
ton pellet was almost near to that of indomethacin. These
data support the hypothesis of the greater effect of the
MEPA on the inflammation in rats. This effect may be due
to the cellular migration to injured sites and accumulation
of collagen an mucopolysaccharides.
Based on the results it can be concluded that the meth-
anolic extract of leaves of Plumeria acuminata possess an
antiinflammatory property in both acute and chronic
phases of inflammation.
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